Related Experiment Video

Updated: Jun 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Clinical inquiries. Which patients benefit from lowering LDL to <100 mg/dL?

Ann Evensen1, Marguerite Elliott, Christopher Hooper-Lane

  • 1University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.

The Journal of Family Practice
|December 8, 2010
PubMed

Insights

Patients with coronary heart disease (CHD) or high risk should target low-density lipoprotein (LDL) below 100 mg/dL. Very high-risk patients may benefit from an LDL target below 70 mg/dL, with statins recommended for high-risk individuals.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • Coronary heart disease (CHD) poses significant health risks.
  • Managing low-density lipoprotein (LDL) cholesterol is crucial for cardiovascular health.
  • Current guidelines recommend specific LDL targets for different risk groups.

Purpose of the Study:

  • To define optimal low-density lipoprotein (LDL) cholesterol targets for patients with coronary heart disease (CHD) or at high risk.
  • To evaluate the role of statin therapy in managing high-risk cardiovascular patients.
  • To provide evidence-based recommendations for LDL cholesterol management.

Main Methods:

  • Review of clinical guidelines and expert opinions.
  • Analysis of evidence from large randomized controlled trials (RCTs) and meta-analyses.
  • Assessment of treatment benefits irrespective of baseline LDL levels or reduction achieved.

Main Results:

  • Recommended LDL target for high-risk CHD patients is <100 mg/dL.
  • An LDL target of <70 mg/dL is a viable option for very-high-risk patients (SOR: C).
  • High-risk patients benefit from statin therapy, preferably high-dose, regardless of baseline LDL (SOR: A).

Conclusions:

  • Statin therapy is beneficial for high-risk patients in CHD prevention.
  • Tailoring LDL targets based on patient risk stratification is essential.
  • Evidence supports aggressive LDL reduction strategies in specific high-risk populations.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...